Streamline Health® Reports Second Quarter 2014 Revenues of $7.2 Million; Adjusted EBITDA $0.5 Million

Loading...
Loading...

Second Quarter Recurring Revenue Up 12% Over Q2 2013

ATLANTA, Sept. 9, 2014 /PRNewswire/ -- Streamline Health Solutions, Inc. STRM, a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced financial results for the second quarter of 2014, which ended July 31, 2014.

Revenues for the three-month period ended July 31, 2014, decreased approximately 17% to $7.2 million versus $8.8 million in the comparable period of fiscal 2013.  Second quarter 2013 revenues included a $1.8 million perpetual license contract, excluding that, revenues for the second quarter 2014 increased approximately 3% over same period year ago.  Recurring revenues increased 4% quarter over quarter and are up 13% YTD over the comparable first six months of fiscal 2013.

"I'm pleased to report that our deal velocity has started to accelerate as we signed a master service agreement with a new, very large channel partner, expected to be worth nearly $7.5 million in bookings.  However, we were unable to finalize the formal order form in time for this to contribute to bookings in Q2, so these new bookings will simply roll into Q3 when completed", stated Robert E. Watson, President and CEO, Streamline Health Solutions, Inc.  "This new agreement utilizes our Abstracting workflow, which is part of our HIM, Coding and CDI solution suite, thereby enabling this channel partner to deliver our solutions to their existing or new clients - wherever the opportunity exists. It is important to note that we are deploying our solutions in a way that we can empower other potential channel partners to do this as well."

Highlights for the second quarter ended July 31, 2014 included:

  • Revenue for the second quarter 2014 was $7.2 million;
  • Adjusted EBITDA for the second quarter 2014 was $0.5 million;
  • Recorded net loss of $2.3 million for the three-month period ended July 31, 2014;
  • Maintenance and support revenues for the quarter increased $0.6 million over the same period year ago;
  • New sales bookings and long term renewal agreements for the quarter were $5.8 million, comprised of $5.0 million in renewals and $0.8 million in new bookings; and
  • Backlog at the end of the quarter was $61.5 million.

Conference Call Information

The Company will conduct a conference call to review the results on Tuesday, September 9, 2014 at 5:00 PM EDT. Interested parties can access the call by dialing 888-337-8169 and mention Conference ID 1670029.  A live webcast will also be available; click here to register.

A replay of the conference call will be available from Tuesday, September 9, 2014 at 7:00 PM EDT to Sunday, September 14, 2014 at 7:00 PM EDT by dialing 888-203-1112 and entering passcode 1670029.

*Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees . A table illustrating this measure is included in this press release.

About Streamline Health
Streamline Health Solutions, Inc. STRM is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge­ – actionable insights that reduce exposure to risk, enhance operational performance, and improve patient care. Through our Looking Glass™ Platform we provide clients with meaningful, intelligent SaaS-based solutions from patient engagement to reimbursement. We share a common calling and commitment to advance the quality of life and the quality of healthcare – for society, our industry, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, backlog, renewal sales and related expectations and assumptions.  These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:
Randy Salisbury
SVP, Chief Marketing Officer
(404)-229-4242
randy.salisbury@streamlinehealth.net


 

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

 



Three Months Ended


Six Months Ended



July 31,


July 31,



2014


2013


2014


2013

Revenues:









  Systems sales

$

314,085

$

2,233,668

$

653,291

$

$2,558,314

  Professional services


674,999


1,039,240


1,283,950


1,958,591

  Maintenance and support


4,177,165


3,620,446


8,348,977


7,001,046

  Software as a service


2,075,823


1,880,007


3,907,025


3,728,748

        Total revenues


7,242,072


8,773,361


14,193,243


15,246,699










Operating expenses:









  Cost of systems sales


834,324


661,124


1,669,792


1,299,722

  Cost of services


778,691


1,266,744


1,765,116


2,241,206

  Cost of maintenance and support


836,526


795,476


1,796,712


1,780,065

  Cost of software as a service


571,464


514,075


1,343,043


1,093,154

  Selling, general and administrative


4,054,794


3,408,153


8,695,250


6,989,020

  Research and development


2,225,120


1,160,147


4,575,564


2,257,157

        Total operating expenses


9,300,919


7,805,719


19,845,477


15,660,324

Operating income (loss)


(2,058,847)


967,642


(5,652,234)


(413,625)

Other expense (income):









  Interest expense


(173,539)


(587,808)


(343,017)


(1,154,373)

  Miscellaneous income (expenses)


(41,481)


(1,064,163)


1,051,290


(1,806,428)

Loss before income taxes


(2,273,867)


(684,329)


(4,943,961)


(3,374,426)

  Income tax expense


(1,145)


(143,874)


(2,290)


(163,624)

Net loss

$

(2,275,012)

$

(828,203)

$

(4,946,251)

$

$(3,538,050)

Less: deemed dividends on Series A Preferred Shares


(252,583)


(15,510)


(482,349)


(357,146)

Net loss attributable to common shareholders

$

(2,527,595)

$

(843,713)

$

(5,428,600)

$

$(3,895,196)

Basic net loss per common share

$

(0.14)

$

(0.07)

$

(0.30)

$

$(0.31)

Number of shares used in basic per common share computation


18,174,193


12,861,715


18,160,213


12,698,094

Diluted net loss per common share

$

(0.14)

$

(0.07)

$

(0.30)

$

$(0.31)

Number of shares used in diluted per common share computation


18,174,193


12,861,715


18,160,213


12,698,094

 

STREAMLINE HEALTH SOLUTIONS, INC.
Backlog
(Unaudited)
Table A



July 31,
2014


January 31,
2014


July 31,

2013

Streamline Health Software Licenses

$

1,955,000

$

2,230,000

$

2,873,000

Hardware and Third Party Software


238,000


79,000


25,000

Professional Services


6,774,000


7,255,000


7,765,000

Maintenance and Support


25,608,000


25,936,000


24,094,000

Software as a Service


26,908,000


21,073,000


17,123,000

    Total

$

61,483,000

$

56,573,000

$

51,880,000

 

STREAMLINE HEALTH SOLUTIONS, INC.
New Bookings
 (Unaudited)
Table B



Three Months Ended



July 31, 2014



Value


% of Total
Bookings

Streamline Health Software licenses

$

250,000


30%

Software as a service


-


0%

Maintenance and support


56,000


6%

Professional services


504,000


60%

Hardware & third party software


33,000


4%

Total bookings

$

843,000


100%

 

 

Reconciliation of Non-GAAP Financial Measures
(Unaudited)
Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

 

Adjusted EBITDA Reconciliation


Three Months Ended,


Six Months Ended,



July 31, 2014


July 31, 2013


July 31, 2014


July 31, 2013

Net loss

$

(2,275)

$

(828)

$

(4,946)

$

(3,538)

    Interest expense


174


588


343


1,154

    Income tax expense


1


144


2


164

    Depreciation


210


167


361


338

    Amortization of capitalized software  development costs


914


701


1,831


1,396

    Amortization of intangible assets


346


315


705


629

    Amortization of other costs


43


17


71


28

EBITDA


(587)


1,104


(1,633)


171

    Share-based compensation expense


422


358


865


826

    Loss on disposal of fixed assets


83


-


83


-

    Associate severances and other costs
         relating to transactions or corporate restructuring


126


-


576


383

   Non-cash valuation adjustments to assets and liabilities


(46)


1,025


(1,145)


1,710

    Transaction related professional fees, advisory fees and
          other internal direct costs


11


152


175


226

    Other non-recurring operating expenses


489


43


1,063


92

Adjusted EBITDA

$

498

$

2,682

$

(16)

$

3,408

Adjusted EBITDA Margin(1)


7%


31%


-%


22%

Adjusted EBITDA per diluted share









Loss per share – diluted

$

(0.14)

$

(0.07)

$

(0.30)

$

(0.31)

Adjusted EBITDA per adjusted diluted share (2)

$

0.02

$

0.15

$

_

$

0.19










Diluted weighted average shares


18,174,193


12,861,715


18,160,213


12,698,094

    Includable incremental shares — adjusted EBITDA (3)


3,614,119


5,122,243


-


5,167,025

Adjusted diluted shares


21,788,312


17,983,958


18,160,213


17,865,119

 

(1)

Adjusted EBITDA as a percentage of GAAP revenues

(2)

Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.

(3)

The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

Logo - http://photos.prnewswire.com/prnh/20140506/85083

SOURCE Streamline Health Solutions, Inc.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...